UniProt ID | APC5_MOUSE | |
---|---|---|
UniProt AC | Q8BTZ4 | |
Protein Name | Anaphase-promoting complex subunit 5 | |
Gene Name | Anapc5 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 740 | |
Subcellular Localization | ||
Protein Description | Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains (By similarity).. | |
Protein Sequence | MMTNGVVHANLFGIKDWVTPYKIAVLVLLNEMGRTGEGAVSLVERRKLNQLLLPLLQGPDITLSKLYKLIEESCPQLANSVQIRIKLMAEGELKDMEQFFDDLSDSFSGTEPEVHKTSVVGLFLRHMILAYSKLSFSQVFKLYTALQQYFQNGEKKTVEDADMDREDGEKQMEKEELDVSVREEEVSCSGPLSQKQAEFFLSQQAALLKNDETKALTPASLQKELNNLLKFNPDFAEAHYLSYLNNLRVQDVFSSTHSLLHYFDRLILTGAEGKSNGEEGYGRSLRYAALNLAALHCRFGHYQQAELALQEAIRIAQESNDHVCLQHCLSWLYVLGQKRADSYVLLEHSVKKAVHFGLPYLASLGIQSLVQQRAFAGKTANKLMDALKDSDLLHWKHSLSELIDISIAQKTAIWRLYGRSTMALQQAQMLLSMNSLESLNAGVQQNNTESFAVALCHLAELHAEQGCFAAAGEVLKHLKDRFPPNSQHAQLWMLCDQKIQFDRAMNDGKFHLADSLVTGITALNGIEGVYRKAVVLQAQNQMTEAHKLLQKLLTYCQKLKNTEMVISVLLSVAELYWRSSSPTIAMPVLLEALALSKEYRLQYLASETVLNLAYAQLILGIPEQALTLLHMAIEPILADGAVLDKGRAMFLVSKCQVASAASYDPVKKAEALEAAIQNLSEAKNYFAQVDCRERIRDVAYFQARLYHALGKTQERNHCAMIFRQLHQELPAHGVPLINHL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
47 | Ubiquitination | VSLVERRKLNQLLLP HHHHHHHHHHHHHHH | 58.99 | - | |
65 | Ubiquitination | GPDITLSKLYKLIEE CCCCHHHHHHHHHHH | 59.97 | - | |
180 | Phosphorylation | EKEELDVSVREEEVS HHHHHCCHHHHHHCC | 18.34 | 26824392 | |
187 | Phosphorylation | SVREEEVSCSGPLSQ HHHHHHCCCCCCCCH | 13.07 | 27841257 | |
209 | Ubiquitination | SQQAALLKNDETKAL HHHHHHHCCCCHHCC | 64.30 | - | |
217 | Phosphorylation | NDETKALTPASLQKE CCCHHCCCHHHHHHH | 22.97 | 26745281 | |
220 | Phosphorylation | TKALTPASLQKELNN HHCCCHHHHHHHHHH | 32.32 | 28066266 | |
223 | Ubiquitination | LTPASLQKELNNLLK CCHHHHHHHHHHHHH | 70.26 | - | |
274 | Ubiquitination | ILTGAEGKSNGEEGY HHCCCCCCCCCCCCC | 32.05 | - | |
349 | Phosphorylation | SYVLLEHSVKKAVHF CHHHHHHHHHHHHHC | 26.68 | - | |
388 | Ubiquitination | NKLMDALKDSDLLHW HHHHHHHCCCCCHHH | 57.83 | - | |
390 | Phosphorylation | LMDALKDSDLLHWKH HHHHHCCCCCHHHCC | 28.68 | - | |
398 | Phosphorylation | DLLHWKHSLSELIDI CCHHHCCCHHHHHHH | 29.84 | - | |
400 | Phosphorylation | LHWKHSLSELIDISI HHHCCCHHHHHHHHH | 33.11 | - | |
406 | Phosphorylation | LSELIDISIAQKTAI HHHHHHHHHHHHHHH | 14.23 | - | |
509 | Ubiquitination | DRAMNDGKFHLADSL HHHHCCCCCCHHHHH | 32.26 | - | |
562 | Phosphorylation | YCQKLKNTEMVISVL HHHHCCCHHHHHHHH | 24.70 | 23140645 | |
571 | Phosphorylation | MVISVLLSVAELYWR HHHHHHHHHHHHHHH | 18.34 | 23140645 | |
706 | Phosphorylation | AYFQARLYHALGKTQ HHHHHHHHHHHCCCC | 4.58 | 28066266 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of APC5_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of APC5_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of APC5_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
BUB1B_HUMAN | BUB1B | physical | 20360068 | |
CDC16_HUMAN | CDC16 | physical | 20360068 | |
CDC23_HUMAN | CDC23 | physical | 20360068 | |
CDC27_HUMAN | CDC27 | physical | 20360068 | |
APC5_HUMAN | ANAPC5 | physical | 20360068 | |
APC1_HUMAN | ANAPC1 | physical | 20360068 | |
CDC26_HUMAN | CDC26 | physical | 20360068 | |
APC4_HUMAN | ANAPC4 | physical | 20360068 | |
CDC20_HUMAN | CDC20 | physical | 20360068 | |
APC7_HUMAN | ANAPC7 | physical | 20360068 | |
ANC2_HUMAN | ANAPC2 | physical | 20360068 | |
ABL1_HUMAN | ABL1 | physical | 26496610 | |
CDC27_HUMAN | CDC27 | physical | 26496610 | |
M3K3_HUMAN | MAP3K3 | physical | 26496610 | |
CDC23_HUMAN | CDC23 | physical | 26496610 | |
CDC16_HUMAN | CDC16 | physical | 26496610 | |
ANC2_HUMAN | ANAPC2 | physical | 26496610 | |
WDR33_HUMAN | WDR33 | physical | 26496610 | |
APC1_HUMAN | ANAPC1 | physical | 26496610 | |
FIP1_HUMAN | FIP1L1 | physical | 26496610 | |
APC16_HUMAN | ANAPC16 | physical | 26496610 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...